Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696994 · ClinicalTrials.gov registry record · NA
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
A NA study of Ovarian Carcinoma and Ovarian Germ Cell Tumor, sponsored by National Cancer Institute (NCI).
- Active
- Registry status
- NA
- Development phase
- 78,216
- Enrollment target
- 1
- Study location
NCT01696994: Active NA study of Ovarian Carcinoma and Ovarian Germ Cell Tumor, sponsored by National Cancer Institute (NCI).
NCT01696994 is a NA study of Ovarian Carcinoma and Ovarian Germ Cell Tumor that is active but no longer recruiting, run by National Cancer Institute (NCI). The registered enrollment target is 78,216 participants, above the 1,009-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (7652% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01696994, a NA study of Ovarian Carcinoma and Ovarian Germ Cell Tumor, is active but no longer recruiting, sponsored by National Cancer Institute (NCI).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 78,216 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tests are part of a trial that addresses the screening of four cancer sites, each with their own results record: prostate (NCT00002540), lung (NCT01696968), colorectal (NCT01696981), and ovarian (NCT01696994).
Primary Outcome
Ovarian cancer deaths confirmed in participants by a death review committee if available, otherwise by death certificate.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Ultrasound Imaging
- OTHER Screening Questionnaire Administration
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78,216 participants |
| Start Date | 1993-11-16 |
| Est. Completion | 2026-03-25 |
| Phase | NA |
What the registry record for NCT01696994 still lists
NCT01696994 is an interventional study that assigns participants to a tested intervention. Its 78,216 participants enrollment target places it among the larger protocols in the corpus, above the 1,009-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (7652% higher).
The record links to 2 conditions, with Ovarian Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01696994 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01696994 about?
NCT01696994 is a clinical study titled "Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)". This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tes...
What is the current status of trial NCT01696994?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 78,216 participants. The study started on 1993-11-16. Estimated completion is 2026-03-25.
What conditions does trial NCT01696994 study?
This clinical trial studies the following conditions: Ovarian Carcinoma, Ovarian Germ Cell Tumor.
What interventions are being tested in trial NCT01696994?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Ultrasound Imaging (PROCEDURE), Screening Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT01696994?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01696994 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01696994's enrollment target sits among peer trials
78,216 1st of 35 higher than 35 of 35 other Ovarian Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
RECRUITING · NA
-
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
RECRUITING · NA
-
Access to Genetic Testing in Underserved Patients With Cancer
RECRUITING · NA
-
The Vanguard Study: Testing a New Way to Screen for Cancer
RECRUITING · NA
-
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00063063 · 80,000 participants
Generic Database of Very Low Birth Weight Infants
- NCT06625983 · 80,000 participants · NA
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
- NCT05701111 · 80,800 participants · NA
Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress
- NCT02402244 · 75,000 participants
Project: Every Child for Younger Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI